marketcaparena
Search

    CATX

    Perspective Therapeutics, Inc.

    Company overview

    Market capitalization
    $285.38M
    Employees
    163
    Latest publication
    2026-09-29
    About Perspective Therapeutics, Inc.

    Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta emitting therapy; VMT01, which is in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma; and PSV359, a targeted alpha therapy targeting fibroblast activation protein alpha. The company also develops Pluvicto, a betaemitting radioligand therapy to treat progressive prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer. It has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 2004 and is headquartered in Seattle, Washington.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue81,000USD76,000USD43,000USD209,000USD290,000USD342,000USD0USD0USD
    Research Development21,544,000USD20,246,000USD32,924,000USD20,339,000USD12,174,000USD14,332,000USD12,883,000USD12,028,000USD
    Total Operating Expenses29,339,000USD27,231,000USD39,832,000USD27,295,000USD23,596,000USD21,832,000USD46,438,000USD18,634,000USD
    Net Income-26,983,000USD-26,189,000USD-37,490,000USD-25,969,000USD-21,485,000USD-18,177,000USD-40,169,000USD-15,122,000USD
    Cost Of Revenue—1,126,000USD1,011,000USD775,000USD733,000USD732,000USD——
    Gross Profit—-1,050,000USD-968,000USD-566,000USD-443,000USD-390,000USD——
    Selling General Administrative—6,985,000USD6,951,000USD7,731,000USD7,709,000USD7,842,000USD8,246,000USD6,975,000USD
    Operating Income—-28,281,000USD-39,832,000USD-27,861,000USD-24,039,000USD-21,832,000USD-44,984,000USD-18,634,000USD
    Interest Income—2,197,000USD1,614,000USD1,957,000USD2,159,000USD2,384,000USD2,647,000USD3,581,000USD
    Interest Expense—105,000USD64,000USD65,000USD119,000USD128,000USD73,000USD69,000USD
    Net Interest Income—2,092,000USD1,550,000USD1,892,000USD2,040,000USD2,256,000USD2,720,000USD3,512,000USD
    Income Before Tax—-26,189,000USD-38,283,000USD-25,969,000USD-21,999,000USD-18,177,000USD-42,266,000USD-15,122,000USD
    Net Income From Continuing Ops—-26,189,000USD-37,490,000USD-25,969,000USD-21,999,000USD-18,177,000USD-40,169,000USD-15,122,000USD
    Ebit—-28,281,000USD-38,219,000USD-25,904,000USD-21,880,000USD-18,049,000USD-42,339,000USD-15,053,000USD
    Ebitda—-27,155,000USD-37,208,000USD-25,129,000USD-21,147,000USD-17,317,000USD-41,618,000USD-14,384,000USD
    Depreciation And Amortization—1,126,000USD1,011,000USD775,000USD733,000USD732,000USD721,000USD669,000USD
    Reconciled Depreciation—1,126,000USD1,011,000USD775,000USD733,000USD732,000USD721,000USD669,000USD
    Total Other Income Expense Net—2,092,000USD1,549,000USD1,892,000USD2,040,000USD3,655,000USD2,718,000USD3,512,000USD
    Income Tax Expense——-793,000USD—-2,097,000USD—-2,097,000USD—
    Unclassified Operating Expenses————3,713,000USD—25,309,000USD—
    Tax Provision——————-2,097,000USD0USD
    SourceDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue884,000USD0USD1,434,000USD7,104,000USD10,795,000USD10,053,000USD9,680,000USD7,314,000USD
    Cost Of Revenue3,251,000USD——5,470,000USD6,179,000USD4,932,000USD4,556,000USD4,267,000USD
    Gross Profit-2,367,000USD—1,434,000USD1,634,000USD4,616,000USD5,121,000USD5,124,000USD3,047,000USD
    Research Development84,215,000USD41,638,000USD21,311,000USD2,602,000USD2,582,000USD1,427,000USD1,126,000USD1,474,000USD
    Selling General Administrative30,233,000USD26,613,000USD20,967,000USD10,866,000USD9,425,000USD4,691,000USD4,571,000USD4,172,000USD
    Total Operating Expenses113,564,000USD92,340,000USD42,375,000USD17,426,000USD18,186,000USD8,558,000USD8,600,000USD8,325,000USD
    Operating Income-113,564,000USD10,459,000USD-40,941,000USD-15,182,000USD-7,391,000USD-3,437,000USD-3,476,000USD-5,278,000USD
    Interest Income8,114,000USD10,515,000USD934,000USD—119,000USD59,000USD30,000USD—
    Interest Expense376,000USD48,000USD84,000USD119,000USD———29,000USD
    Net Interest Income7,738,000USD10,467,000USD850,000USD—119,000USD59,000USD30,000USD—
    Income Before Tax-104,428,000USD-81,376,000USD-40,106,000USD-14,670,000USD-7,272,000USD-3,387,000USD-3,446,000USD-5,144,000USD
    Income Tax Expense-793,000USD-2,097,000USD-2,651,000USD-119,000USD—-199,000USD-177,000USD-294,000USD
    Tax Provision-793,000USD-2,097,000USD-2,651,000USD—————
    Net Income-103,121,000USD-79,279,000USD-46,508,000USD-14,670,000USD-7,272,000USD-3,188,000USD-3,269,000USD-4,850,000USD
    Net Income From Continuing Ops-103,635,000USD-78,330,000USD-37,455,000USD—-7,272,000USD-3,387,000USD-3,446,000USD—
    Ebit-104,052,000USD—-40,941,000USD-15,182,000USD—-3,437,000USD-3,623,000USD-5,278,000USD
    Ebitda-100,801,000USD10,459,000USD-39,960,000USD-14,838,000USD—-3,428,000USD-3,476,000USD-5,302,000USD
    Depreciation And Amortization3,251,000USD—981,000USD344,000USD—9,000USD147,000USD-24,000USD
    Reconciled Depreciation3,251,000USD2,306,000USD946,000USD—248,000USD149,000USD147,000USD—
    Total Other Income Expense Net9,136,000USD-91,835,000USD835,000USD512,000USD—50,000USD30,000USD134,000USD
    Unclassified Operating Expenses—24,089,000USD——6,179,000USD———
    Selling And Marketing Expenses——97,000USD3,228,000USD—2,440,000USD2,976,000USD2,679,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets392,025,000USD410,769,000USD266,972,000USD294,825,000USD310,725,000USD329,349,000USD341,101,000USD391,153,000USD
    Cash And Equivalents48,488,000USD———————
    Total Current Assets241,523,000USD275,352,000USD148,389,000USD178,500,000USD195,958,000USD215,742,000USD231,160,000USD270,172,000USD
    Total Liabilities68,162,000USD———————
    Total Current Liabilities36,544,000USD31,486,000USD28,679,000USD20,618,000USD12,986,000USD12,679,000USD18,230,000USD28,143,000USD
    Net Receivables269,000USD58,000USD6,000USD179,000USD225,000USD78,000USD1,483,000USD217,000USD
    Property Plant Equipment Net107,797,000USD94,927,000USD78,097,000USD65,887,000USD64,366,000USD63,241,000USD59,536,000USD46,225,000USD
    Intangible Assets—40,000,000USD40,000,000USD50,000,000USD50,000,000USD50,000,000USD50,011,000USD50,000,000USD
    Other Current Assets—4,365,000USD3,646,000USD4,184,000USD4,155,000USD3,962,000USD4,128,000USD2,108,000USD
    Total Liab—63,331,000USD59,941,000USD52,609,000USD45,033,000USD44,704,000USD50,433,000USD62,682,000USD
    Total Stockholder Equity—347,438,000USD207,031,000USD242,216,000USD265,692,000USD284,645,000USD290,668,000USD328,471,000USD
    Other Current Liab—3,817,000USD1,456,000USD6,911,000USD5,037,000USD2,912,000USD5,478,000USD3,976,000USD
    Common Stock—114,000USD74,000USD74,000USD74,000USD73,000USD70,000USD67,000USD
    Capital Stock—114,000USD74,000USD74,000USD74,000USD73,000USD70,000USD67,000USD
    Retained Earnings—-361,029,000USD-334,840,000USD-297,350,000USD-271,381,000USD-249,896,000USD-231,719,000USD-191,550,000USD
    Cash—53,972,000USD30,629,000USD26,762,000USD28,849,000USD44,406,000USD61,580,000USD226,443,000USD
    Cash And Short Term Investments—270,929,000USD144,737,000USD174,137,000USD191,578,000USD211,702,000USD226,916,000USD267,847,000USD
    Current Deferred Revenue—26,600,000USD26,600,000USD—26,600,000USD—1,400,000USD1,400,000USD
    Net Debt—-51,351,000USD-29,001,000USD-23,449,000USD-25,280,000USD-40,588,000USD-57,518,000USD-222,175,000USD
    Short Term Debt—1,069,000USD623,000USD759,000USD901,000USD1,033,000USD1,009,000USD954,000USD
    Short Long Term Debt—56,000USD56,000USD55,000USD54,000USD53,000USD52,000USD51,000USD
    Short Long Term Debt Total—2,621,000USD1,628,000USD3,313,000USD3,569,000USD3,818,000USD4,062,000USD4,268,000USD
    Long Term Debt—1,554,000USD1,569,000USD1,583,000USD1,597,000USD1,611,000USD1,625,000USD1,638,000USD
    Short Term Investments—216,957,000USD114,108,000USD147,375,000USD162,729,000USD167,296,000USD165,336,000USD41,404,000USD
    Accounts Payable—26,485,000USD20,511,000USD12,948,000USD7,048,000USD8,734,000USD10,343,000USD21,813,000USD
    Property Plant Equipment Gross—102,255,000USD84,301,000USD71,082,000USD68,788,000USD66,931,000USD62,496,000USD48,479,000USD
    Accumulated Other Comprehensive Income—-226,000USD110,000USD114,000USD3,000USD19,000USD-51,000USD—
    Common Stock Shares Outstanding—103,604,000shares73,813,000shares74,296,000shares70,671,464shares72,357,000shares70,629,000shares70,629,000shares
    Non Current Assets Total—135,417,000USD118,583,000USD116,325,000USD114,767,000USD113,607,000USD109,941,000USD120,981,000USD
    Non Current Liabilities Total—31,845,000USD31,262,000USD31,991,000USD32,047,000USD32,025,000USD32,203,000USD34,539,000USD
    Non Current Liabilities Other—437,000USD386,000USD342,000USD284,000USD145,000USD55,000USD33,000USD
    Non Currrent Assets Other—490,000USD486,000USD438,000USD401,000USD366,000USD72,000USD694,000USD
    Net Working Capital—243,866,000USD119,710,000USD157,882,000USD182,972,000USD203,063,000USD212,930,000USD242,029,000USD
    Unclassified Current Liabilities—-26,541,000USD-20,567,000USD—-26,654,000USD———
    Unclassified Non Current Liabilities—29,854,000USD29,307,000USD30,066,000USD30,166,000USD30,269,000USD30,523,000USD32,868,000USD
    Unclassified Equity—708,465,000USD541,613,000USD539,304,000USD536,922,000USD534,376,000USD522,298,000USD519,887,000USD
    Long Term Investments——275,000USD———322,000USD—
    Good Will——————0USD24,062,000USD
    Inventory——————-1,367,000USD—
    SourceDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets266,972,000USD341,101,000USD97,891,000USD58,091,000USD64,439,000USD15,513,000USD8,699,000USD9,422,000USD
    Intangible Assets40,000,000USD50,000,000USD50,354,000USD86,000USD107,000USD130,000USD138,000USD162,000USD
    Other Current Assets3,646,000USD4,128,000USD6,424,000USD6,686,000USD27,000USD301,000USD426,000USD305,000USD
    Total Liab59,941,000USD50,433,000USD22,712,000USD3,449,000USD3,162,000USD2,740,000USD2,976,000USD1,742,000USD
    Total Stockholder Equity207,031,000USD290,668,000USD75,179,000USD54,642,000USD61,277,000USD12,773,000USD5,723,000USD7,680,000USD
    Other Current Liab1,456,000USD5,478,000USD8,660,000USD-406,000USD—385,000USD333,000USD349,000USD
    Common Stock74,000USD70,000USD282,000USD142,000USD—87,000USD69,000USD67,000USD
    Capital Stock74,000USD70,000USD282,000USD—142,000USD142,000USD69,000USD—
    Retained Earnings-334,840,000USD-231,719,000USD-152,440,000USD-105,932,000USD-98,597,000USD-89,519,000USD-87,938,000USD-84,492,000USD
    Cash30,629,000USD61,580,000USD9,238,000USD20,993,000USD55,890,000USD9,585,000USD2,392,000USD5,326,000USD
    Cash And Short Term Investments144,737,000USD226,916,000USD9,238,000USD43,757,000USD—9,585,000USD2,392,000USD5,326,000USD
    Total Current Assets148,389,000USD231,160,000USD16,837,000USD53,215,000USD59,329,000USD12,289,000USD5,507,000USD7,315,000USD
    Total Current Liabilities28,679,000USD18,230,000USD15,664,000USD2,676,000USD2,266,000USD1,335,000USD1,575,000USD1,121,000USD
    Current Deferred Revenue26,600,000USD1,400,000USD——————
    Net Debt-29,001,000USD-57,518,000USD-6,687,000USD-20,993,000USD—-8,688,000USD-1,387,000USD-5,326,000USD
    Short Term Debt623,000USD1,009,000USD95,000USD260,000USD—245,000USD236,000USD—
    Short Long Term Debt56,000USD52,000USD49,000USD—————
    Short Long Term Debt Total1,628,000USD4,062,000USD2,551,000USD652,000USD—897,000USD1,005,000USD—
    Long Term Debt1,569,000USD1,625,000USD1,676,000USD—————
    Long Term Investments275,000USD322,000USD133,000USD—0USD0USD——
    Short Term Investments114,108,000USD165,336,000USD0USD22,764,000USD0USD0USD—825,000USD
    Net Receivables6,000USD116,000USD1,175,000USD1,363,000USD1,608,000USD1,738,000USD2,044,000USD1,154,000USD
    Accounts Payable20,511,000USD10,343,000USD6,909,000USD1,541,000USD966,000USD494,000USD654,000USD683,000USD
    Property Plant Equipment Net78,097,000USD59,536,000USD6,323,000USD2,062,000USD2,488,000USD2,721,000USD2,736,000USD1,609,000USD
    Property Plant Equipment Gross84,301,000USD62,496,000USD6,992,000USD—9,984,000USD9,974,000USD10,253,000USD—
    Accumulated Other Comprehensive Income110,000USD-51,000USD—————-7,671,000USD
    Common Stock Shares Outstanding73,813,000shares64,425,000shares54,905,650shares54,905,650shares14,204,026shares54,905,650shares67,601,000shares67,042,000shares
    Non Current Assets Total118,583,000USD109,941,000USD81,054,000USD2,298,000USD5,110,000USD3,224,000USD3,192,000USD2,107,000USD
    Non Current Liabilities Total31,262,000USD32,203,000USD7,048,000USD1,016,000USD896,000USD1,405,000USD1,401,000USD621,000USD
    Non Current Liabilities Other386,000USD55,000USD——————
    Non Currrent Assets Other486,000USD405,000USD182,000USD-2,298,000USD2,515,000USD373,000USD137,000USD155,000USD
    Net Working Capital119,710,000USD212,930,000USD1,173,000USD—57,063,000USD65,501,000USD3,932,000USD—
    Unclassified Current Liabilities-20,567,000USD———1,300,000USD———
    Unclassified Non Current Liabilities29,307,000USD30,523,000USD5,372,000USD1,016,000USD—1,405,000USD1,401,000USD—
    Unclassified Equity541,613,000USD522,298,000USD227,055,000USD160,432,000USD159,732,000USD102,063,000USD93,523,000USD99,776,000USD
    Good Will—0USD24,062,000USD—————
    Other Assets———2,578,000USD————
    Inventory———1,409,000USD1,396,000USD665,000USD645,000USD530,000USD
    Unclassified Non Current Assets———-2,428,000USD————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-26,189,000USD-37,490,000USD-25,969,000USD-21,485,000USD-18,177,000USD-40,169,000USD-15,122,000USD-11,704,000USD
    Depreciation1,126,000USD1,011,000USD775,000USD733,000USD732,000USD721,000USD669,000USD570,000USD
    Stock Based Compensation2,553,000USD2,309,000USD2,156,000USD2,403,000USD2,098,000USD2,060,000USD1,952,000USD719,000USD
    Other Non Cash Items2,141,000USD8,826,000USD-544,000USD-691,000USD-852,000USD24,316,000USD-485,000USD10,000USD
    Change To Account Receivables-444,000USD336,000USD27,000USD-359,000USD-36,000USD159,000USD1,315,000USD857,000USD
    Change In Working Capital-8,546,000USD687,000USD7,290,000USD-913,000USD-5,383,000USD-11,437,000USD16,352,000USD1,503,000USD
    Total Cash From Operating Activities-31,468,000USD-24,657,000USD-16,292,000USD-19,953,000USD-21,582,000USD-26,606,000USD3,366,000USD-8,902,000USD
    Capital Expenditures-6,858,000USD-5,075,000USD-1,992,000USD-1,026,000USD-4,656,000USD-14,614,000USD-29,713,000USD-1,015,000USD
    Free Cash Flow-38,326,000USD-29,732,000USD-18,284,000USD-20,979,000USD-26,238,000USD-41,220,000USD-26,347,000USD-9,917,000USD
    Investments-102,695,000USD33,663,000USD16,023,000USD4,264,000USD-5,565,000USD-138,602,000USD-29,737,000USD-3,295,000USD
    Total Cashflows From Investing Activities-109,553,000USD28,537,000USD13,992,000USD4,264,000USD-5,565,000USD-138,602,000USD-29,737,000USD-3,295,000USD
    Net Borrowings-15,000USD-13,000USD-13,000USD-13,000USD-13,000USD-12,000USD-16,000USD—
    Total Cash From Financing Activities164,364,000USD-13,000USD213,000USD132,000USD9,973,000USD345,000USD628,000USD122,084,000USD
    Issuance Of Capital Stock164,089,000USD-371,000USD371,000USD0USD9,986,000USD-13,144,000USD-123,000USD235,037,000USD
    Change In Cash23,343,000USD3,867,000USD-2,087,000USD-15,557,000USD-17,174,000USD-164,863,000USD-25,743,000USD109,887,000USD
    Begin Period Cash Flow30,629,000USD26,762,000USD28,849,000USD44,406,000USD61,580,000USD226,443,000USD252,186,000USD142,299,000USD
    End Period Cash Flow53,972,000USD30,629,000USD26,762,000USD28,849,000USD44,406,000USD61,580,000USD226,443,000USD252,186,000USD
    Other Cashflows From Financing Activities164,364,000USD371,000USD—9,240,000USD—12,248,000USD644,000USD-112,945,000USD
    Unclassified Operating Cash Flow-2,553,000USD————-2,097,000USD——
    Unclassified Financing Cash Flow-164,074,000USD——-9,095,000USD—1,253,000USD——
    Change To Inventory—340,000USD0USD-170,000USD0USD0USD0USD-16,000USD
    Other Cashflows From Investing Activities—-51,000USD-39,000USD-36,000USD-9,000USD287,000USD-24,000USD—
    Unclassified Investing Cash Flow———1,062,000USD4,665,000USD14,327,000USD29,737,000USD1,015,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-103,121,000USD-79,279,000USD-46,508,000USD-14,670,000USD-7,272,000USD-3,387,000USD-3,446,000USD-5,144,000USD
    Depreciation3,251,000USD2,306,000USD946,000USD344,000USD248,000USD149,000USD147,000USD136,000USD
    Stock Based Compensation8,966,000USD5,387,000USD3,738,000USD1,344,000USD1,087,000USD386,000USD495,000USD420,000USD
    Other Non Cash Items7,532,000USD55,389,000USD5,266,000USD472,000USD77,000USD72,000USD-2,000USD81,000USD
    Change To Account Receivables-32,000USD1,049,000USD-426,000USD490,000USD—31,000USD-890,000USD38,000USD
    Change To Inventory0USD11,000USD359,000USD-152,000USD-2,673,000USD-274,000USD-97,000USD128,000USD
    Change In Working Capital1,681,000USD31,814,000USD2,296,000USD338,000USD-1,850,000USD-67,000USD-835,000USD-518,000USD
    Total Cash From Operating Activities-82,484,000USD-18,294,000USD-36,913,000USD-12,172,000USD-7,710,000USD-2,837,000USD-3,641,000USD-5,049,000USD
    Capital Expenditures-12,749,000USD-54,414,000USD-1,072,000USD-302,000USD-266,000USD-381,000USD-273,000USD-444,000USD
    Free Cash Flow-95,233,000USD-72,708,000USD-37,985,000USD-12,474,000USD-7,976,000USD-3,218,000USD-3,914,000USD-5,493,000USD
    Investments54,112,000USD-218,931,000USD24,373,000USD—0USD-410,000USD-287,000USD—
    Total Cashflows From Investing Activities41,228,000USD-218,931,000USD24,373,000USD-57,678,000USD—-410,000USD-287,000USD401,000USD
    Net Borrowings-52,000USD-48,000USD-68,000USD—————
    Total Cash From Financing Activities10,305,000USD289,385,000USD785,000USD56,000USD56,000USD64,684,000USD994,000USD7,374,000USD
    Issuance Of Capital Stock9,986,000USD275,932,000USD364,000USD—0USD64,693,000USD1,005,000USD—
    Change In Cash-30,951,000USD52,160,000USD-46,652,000USD182,000USD-7,938,000USD61,437,000USD-2,934,000USD2,726,000USD
    Begin Period Cash Flow61,580,000USD9,420,000USD21,175,000USD55,890,000USD64,010,000USD2,573,000USD5,507,000USD2,781,000USD
    End Period Cash Flow30,629,000USD61,580,000USD9,420,000USD56,072,000USD56,072,000USD64,010,000USD2,573,000USD5,507,000USD
    Other Cashflows From Investing Activities-135,000USD78,993,000USD-18,000USD-57,376,000USD—-30,000USD-14,000USD-14,000USD
    Other Cashflows From Financing Activities10,305,000USD289,385,000USD489,000USD56,000USD—-410,000USD-287,000USD401,000USD
    Unclassified Financing Cash Flow-9,934,000USD-275,884,000USD—————6,984,000USD
    Unclassified Operating Cash Flow—-33,911,000USD-2,651,000USD—————
    Unclassified Investing Cash Flow—-24,579,000USD1,090,000USD—————
    Dividends Paid————0USD-9,000USD-11,000USD-11,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q3 2023Quarterly · 2023-09-30SegmentBrachytherapy1,909,000USD0001437749-23-032036
    Q3 2023Quarterly · 2023-09-30SegmentDrug Operations276,000USD0001437749-23-032036
    Q2 2023Quarterly · 2023-06-30SegmentBrachytherapy1,500,000USD0001437749-23-023340
    Q2 2023Quarterly · 2023-06-30SegmentDrug Operations588,000USD0001437749-23-023340
    Q1 2023Quarterly · 2023-03-31SegmentBrachytherapy1,830,000USD0001437749-23-014658
    Q1 2023Quarterly · 2023-03-31SegmentDrug Operations233,000USD0001437749-23-014658
    Q3 2022Quarterly · 2022-09-30SegmentBrachytherapy1,717,000USD0001437749-23-032036
    Q3 2022Quarterly · 2022-09-30SegmentDrug Operations0USD0001437749-23-032036
    Q2 2022Quarterly · 2022-06-30SegmentBrachytherapy2,505,000USD0001437749-23-023340
    Q2 2022Quarterly · 2022-06-30SegmentDrug Operations0USD0001437749-23-023340
    Q1 2022Quarterly · 2022-03-31SegmentBrachytherapy2,910,000USD0001437749-23-014658
    Q1 2022Quarterly · 2022-03-31SegmentDrug Operations0USD0001437749-23-014658

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.